MetaVia is trading 6.72% higher at $1.43 after closing at $1.34 on November 4; no company-specific explanation for the after-hours move has been verified.
- The regular-session close rose 6.35% after gains on the prior two sessions; the broader market also advanced and may have supported sentiment.
- MetaVia presented previously announced Phase 1 DA-1726 data at the Precision Liver Symposium on November 4. The presentation was announced October 28, so it is not a confirmed new catalyst.
- After-hours trading volume is unavailable.